Maze Therapeutics, Inc. · NASDAQ:MAZE

Frazier Life Sciences Public Fund, L.P. reported a 7.70% stake in Maze Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2025 · Filed Aug 14, 2025

Frazier Life Sciences Public Fund, L.P. reported a 7.70% stake in Maze Therapeutics, Inc., 3,352,915 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).

Stake
7.70%
Shares
3,352,915
Intent
Passive
What changed
Stake changed
Filed together
17 holders

The filing in full

HolderStakeShares
Frazier Life Sciences Public Fund, L.P.7.70%3,352,915
FHMLSP, L.P.7.70%3,352,915
FHMLSP, L.L.C.7.70%3,352,915
Frazier Life Sciences Public Overage Fund, L.P.2.30%989,351
FHMLSP Overage, L.P.2.30%989,351
FHMLSP Overage, L.L.C.2.30%989,351
Frazier Life Sciences X, L.P.0.20%75,982
FHMLS X, L.P.0.20%75,982
FHMLS X, L.L.C.0.20%75,982
Frazier Life Sciences XI, L.P.0.30%149,026
FHMLS XI, L.P.0.30%149,026
FHMLS XI, L.L.C.0.30%149,026
James N. Topper0.20%75,982
Patrick J. Heron0.20%75,982
Albert Cha0%0
James Brush0%0
Daniel Estes0%0

Source

View original at SEC

Related